A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)

Amgen0 个研究点目标入组 1,000 人开始时间: 2004年12月最近更新: 2007年12月28日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Amgen
入组人数: 1,000

研究概览研究设计入排标准研究者记录与标识符相似试验

研究概览

简要总结

Objectives include description of current practices; assessment over time of K/DOQI goals, clinical outcomes, health resource utilization(HRU) and patient reported outcomes (PRO) and the impact of Sensipar® on these parameters

研究设计

研究类型: Observational
时间视角: Prospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•3 month history of Stage 4 or Stage 5 CKD
•A PTH value within 3 months of enrollment
•If relevant, completion of Sensipar® study prior to enrolling in Registry

排除标准

•Females who are pregnant or breast feeding

研究者

发起方

Amgen

申办方类型

Industry

相似试验

已完成

不适用

A Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and NewbornEarly Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN)Erythroblastosis, Fetal

NCT03755128Janssen Research & Development, LLC17

已完成

不适用

Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma

NCT04069468Boston Scientific Corporation1,247

撤回

不适用

Observational Patient Registry of the Dynamic Locking ScrewsProximal or Diaphyseal Humerus FractureDiaphyseal or Distal Femur FractureDiaphyseal, Distal or Proximal Tibia Fracture

NCT02656628Synthes GmbH

已完成

不适用

Cardiogenesis Transmyocardial Revascularization RegistryClass IV Angina

NCT01827319Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.203

已完成

不适用

Hyponatremia Registry for Patients With Euvolemic and Hypervolemic HyponatremiaEuvolemic HyponatremiaHypervolemic Hyponatremia

NCT01240668Otsuka America Pharmaceutical5,028